| Date | Title | Description |
| 20.11.2025 | How EQT uses AI to see the startup world differently | EQT Ventures is one of the largest VC investors in Europe and has raised €2.6 billion across three funds, and invests from Seed up to Series C. Together, EQT Group has invested in over 300 companies, including Einride, Wolt, Marvel Fusion, ... |
| 15.10.2025 | Industry veterans join Lifesciences and fashion-tech startups |
MetaLead Therapeutics, a spinoff of the University of Zurich, has developed a novel metal-binding peptide platform to create best-in-class therapeutics that target pathological metals, restore healthy balance, or deliver therapeutic counte... |
| 12.09.2023 | TOP 100 Investments: Swiss startups remain attractive to investors | TOP 100 Investments: Swiss startups remain attractive to investors 12.09.2023 17:00, Rita Longobardi linkedIn facebook twitter instagram youtube -->
During the first six months of the current year, Swiss startups managed to raise a total... |
| 16.08.2023 | EIC backs Dutch medtech startup Xeltis in €12.5M round for its transformative implants: Know more | Read this article in:
Eindhoven-based Xeltis, a clinical-stage MedTech company, announced on Monday, August 14, that it has secured €12.5M in funding from the European Innovation Council (EIC) Fund, bringing the total amount raised to €44.5... |
| 15.08.2023 | Dutch medtech firm Xeltis secures €12.5M from EIC Fund | Dutch medtech firm Xeltis has secured €12.5 million in funding from the European Innovation Council (EIC) Fund. This brings Xeltis' total amount raised, to date, to €44.5 million. Its investors include DaVita Venture Group, EQT Life Science... |
| 14.08.2023 | Xeltis secures additional €12.5 million from European Innovation Council Fund in final close of D2 financing | Xeltis secures additional €12.5 million from European Innovation Council Fund in final close of D2 financing
Funding extends Xeltis’ Series D2 financing round to €44.5 million
EINDHOVEN, The Netherlands – 14 August 2023, Xeltis a leading de... |
| 14.08.2023 | Xeltis Secures Additional €12.5M in Final Close of D2 financing | Xeltis, an Eindhoven, Netherlands-based developer of implants that enable the natural creation of living and long-lasting vessels, raised additional €12.5M in final close of D2 funding.
The round, which brought the total amount to €44.5M, s... |
| 14.08.2023 | Xeltis secures additional €12.5 million from European Innovation Council Fund in final close of D2 financing | - |
| 23.02.2023 | Eindhoven’s Xeltis raises €32M to develop living implants that help the body restore cardiovascular function | Eindhoven-based Xeltis, a clinical-stage medtech company, announced on Tuesday, February 21, that it has secured €32M in a Series D2 equity fundraising.
The investment came from a syndicate of current and new investors, including Grand Phar... |
| 23.02.2023 | Medtech startup secures €32 million in series D2 round | |
| 21.02.2023 | Xeltis raises €32 million to drive clinical development of world’s most advanced restorative cardiovascular devices | - |
| 28.12.2022 | Eindhoven-based startups that raised €1M+ in 2022 | The city of Eindhoven in the Netherlands may not instantly come to mind as a high-tech powerhouse, but it is eager to establish itself as a hub for deep tech in Europe. According to research by Dealroom.co, Eindhoven is ranked #1 among the ... |
| 11.08.2022 | Xeltis to receive €15 million in its first Asian deal | |
| 10.08.2022 | Dutch medtech startup Xeltis secures €15 million to develop pioneering medical treatments | Xeltis, a Dutch medtech startup, has secured €15 million of fresh investment from Chinese firm, Grand Pharma. The startup is developing medical devices to treat cardiovascular disease and as a result, aims to lessen the incidence of CKD.
Ch... |
| 09.08.2022 | Dutch medtech startup Xeltis secures €15M from China’s Grand Pharmaceutical: here’s why | The Netherlands-based Xeltis, a clinical-stage medical device company, announced on Tuesday that it has raised €15M in a Series D2 round of funding.
The investment came from China-based Grand Pharmaceutical Group. The deal, which primarily ... |
| 22.12.2021 | Largest-ever funding round from EIC Accelerator: EC selects 99 startups to receive €627M; meet the 10 Dutch startups selected | The European Commission has announced the selection of 99 innovative startups and SMEs to be funded under the European Innovation Council (EIC) Accelerator programme. The selected startups will receive €627M of EU funding to help them bring... |
| 30.11.2021 | Xeltis lands €15 million European financing from EIB | |
| 29.11.2021 | Dutch-Swiss medtech firm Xeltis lands €15M from EIB for its restorative approach in cardiovascular therapy | Xeltis, a Swiss-Dutch medical device company, announced that it has secured €15M quasi-equity financing from the European Investment Bank (EIB).
The financing is being made available under the European Guarantee Fund (EGF), a part of the €5... |
| 12.07.2021 | Xeltis' restorative heart valve one step closer to the market | |
| 20.02.2020 | Xeltis trials show promising function of living heart valves restored in children | |
| 20.02.2020 | Xeltis trials show promising function of living heart valves restored in children | Clinical trial results of Xeltis pulmonary valve (PV) show promising functionality of the living valves developed in patients as a result of its restorative implants. Xeltis heart valves provide a home to the patient’s own cells to form new... |
| 20.12.2019 | 8 innovative healthtech startups from Eindhoven that raised funding in 2019 | Earlier, heathtech startups were those that provide enterprise, diagnostic, etc. This scenario has witnessed a drastic change, thanks to the new breed of startups that are mushrooming with the aspiration to solve root causes that lead to me... |
| 06.09.2019 | Xeltis’ closes €10.5 million Series D financing | |
| 06.09.2019 | Swiss medtech startup Xeltis raises €10.5 million to develop its novel tissue regeneration treatment for heart disease | Swiss startup Xeltis has announced the close of a €10.5 million Series D financing round to support its vascular and valve trial programmes. The funding was provided by existing institutional and private investors, including all VCs already... |
| 26.02.2019 | Red Herring Top 100 Europe recognizes Swiss legaltech and medtech startups | |
| 30.05.2018 | Three medtech products with the potential to change lives | |
| 25.04.2018 | Swiss Medtech Day: Award-Finalisten und Programm stehen fest | |
| 16.11.2017 | Term Sheet — Thursday, November 16 | THE HOTTEST CEO IN SILICON VALLEY
Good morning, Term Sheet readers.
Paid Content How can you protect what you can't see? From ExtraHop
Huang, 54, is the cofounder and CEO of semiconductor and software company Nvidia. The company’s “graphic ... |
| 15.11.2017 | Xeltis Completes €45m Series C Financing | Xeltis, an Eindhoven, The Netherlands- and Zurich, Switzerland-based clinical-stage medical device company advancing a restorative approach in heart valve therapy, completed a €45 million ($52m) Series C financing.
The round was led by a gl... |
| 15.11.2017 | La suiza Xeltis cierra una ronda de €45M a la que acude Ysios, un inversor estratégico, institucionales actuales y BA | 15/11/2017
Nota de prensa
LA SUIZA XELTIS CIERRA UNA RONDA DE €45 MILLONES A LA QUE ACUDE YSIOS, UN INVERSO ESTRATÉGICO, INSTITUCIONALES ACTUALES Y BUSINESS ANGELS.
Ysios Capital, gestora española de capital riesgo (venture capital) líde... |
| 15.11.2017 | Xeltis Closes €45 Million in Series C Financing | |
| 15.11.2017 | Swiss medical device company Xeltis raises €45 million Series C round | Medical device firm Xeltis, from Switzerland, has raised €45 million in Series C funding. The lead investor in the round has not been named. Ysios, (LSP, Kurma Partners, VI Partners) and a number of private investors also participated.
Acco... |
| 15.11.2017 | Xeltis mit Rekordfinanzierung | |
| 10.11.2017 | "An IPO has become a serious alternative” | |
| 25.04.2017 | Xeltis wins Gold Edison Award in medical technology | |
| 01.02.2017 | FDA permits Xeltis to begin trials in the USA | |
| 03.10.2016 | First-ever bioabsorbable heart valves in clinic | |
| 23.05.2016 | Xeltis can now commence the clinical study of bioabsorbable heart valve | |
| 17.12.2015 | Xeltis acquires additional €3M in series B financing | |
| 17.12.2015 | Xeltis Completes €30M Series B Financing | Xeltis, a Zurich, Switzerland- and Eindhoven, The Netherlands-based medical device company developing bioabsorbable cardiovascular valves and vessels designed to allow Endogenous Tissue Restoration (ETR), completed a €3m extension of its Se... |
| 07.12.2015 | Three Swiss Life Sciences Start-ups among winners of the European CEO Awards | |
| 03.12.2015 | Xeltis has developed the first bioabsorbable heart valve | The technology was created by professor Jean-Marie Lehn, whose Nobel Prize–winning research on supramolecular chemistry led to its development. The bioabsorable cardiovascular patch essentially works as valves, vessels and tissue until the ... |
| 19.05.2015 | First Xeltis study with encouraging results | |
| 20.02.2015 | Four million euro to develop new blood vessels for kidney dialysis | |
| 05.12.2014 | Amazing innovations at Swiss Venture Day | |
| 02.12.2014 | Xeltis raises $34m for regenerative heart valve tech | Xeltis said today that it closed an over-subscribed Series B round worth about $34 million for the regenerative heart valve technology it’s developing.
Zurich-based Xeltis said the round was led by Amsterdam’s Life Sciences Partners and Par... |
| 02.12.2014 | Xeltis closes CHF 32 million Series B financing | |
| 26.03.2014 | Xeltis Completes Enrolment in World’s First Study of Spontaneous Tissue Growth | |
| 09.01.2014 | Xeltis Appoints Nobel Prize Winner Prof. Jean-Marie Lehn to Its Advisory Board | |
| 18.12.2013 | Winning ventures of IMD Startup Competition announced | pryvChosen from over 100 applicants over the past months, find below the names of the companies who will work with IMD’s MBA and EMBA classes in 2014.
Augurix Diagnostics (EMBA)
Augurix Diagnostics is active in companion diagnostics devices... |
| 05.04.2013 | Xeltis wins ‘Next Gem Award in Medtech’ | |
| 12.03.2012 | Xeltis Announces Approval to Begin First Clinical Study | |
| - | Xeltis | “Home - Xeltis” |
| - | Chinese pharma giant backs Dutch medtech Xeltis with €15 million | The Netherlands-based clinical-stage medical device company Xeltis has raised €15 million in funding from China-based Grand Pharmaceutical Group. The deal will focus on the restorative hemodialysis access device from Xeltis called aXess and... |
| - | Xeltis has developed the first bioabsorbable heart valve | Heart-valve replacement procedures are complicated for many reasons. Having a foreign material in the body presents challenges like increased inflammation and potential revision surgery, which is not only challenging physically for a patien... |
| - | Xeltis | “Xeltis developed the world’s most advanced polymer-based platform of restorative cardiovascular devices.” |
